Asia-Pacific Newsweek
Staff reporter
,
South Korea
Press photos from GemVax and KAEL (via PR Newswire)
The center will promote the treatment, research and potential commercialization of PSP therapies.
Seoul National University Bundang Hospital (SNUBH), CurePSP, Inc. and GemVax & KAEL Co., Ltd. plan to establish Korea's first international progressive supranuclear palsy (PSP) research and treatment center.
The center will leverage the organizations' expertise and infrastructure to promote education, treatment and research, and the potential commercialization of therapies for PSP and other neurological disorders.
The center will also address related issues, including behavioral and neurological disorders related to addiction, with a focus on substance abuse.
The initiative, formalized through a tripartite memorandum of understanding, aims to advance research, treatment and education on PSP and related neurological disorders.
Join the Asian Healthcare Magazine Community
Now that you're here…
….There are many ways you can work with us to promote your company and connect with your customers. Our team can help you plan and create print and digital advertising campaigns on this website and in the print magazine.
We can also organize real-life or digital events for you and source thought leadership speakers as well as industry leaders (who may be your potential partners) to attend your events. We also run a number of awards programs that give you the chance to be recognized for your achievements during the year, and you can join as a participant or sponsor.
Let us help you drive business development through good partnerships!
